184 related articles for article (PubMed ID: 37325478)
1. The XBB.1.5 slightly increase the binding affinity for host receptor ACE2 and exhibit strongest immune escaping features: molecular modeling and free energy calculation.
Suleman M; Murtaza A; ; Khan H; Rashid F; Alshammari A; Ali L; Khan A; Wei DQ
Front Mol Biosci; 2023; 10():1153046. PubMed ID: 37325478
[No Abstract] [Full Text] [Related]
2. Investigation of the binding and dynamic features of A.30 variant revealed higher binding of RBD for hACE2 and escapes the neutralizing antibody: A molecular simulation approach.
Shafiq A; Zubair F; Ambreen A; Suleman M; Yousafi Q; Rasul Niazi Z; Anwar Z; Khan A; Mohammad A; Wei DQ
Comput Biol Med; 2022 Jul; 146():105574. PubMed ID: 35533461
[TBL] [Abstract][Full Text] [Related]
3. Mutational analysis of the spike protein of SARS-COV-2 isolates revealed atomistic features responsible for higher binding and infectivity.
Hanifa M; Salman M; Fatima M; Mukhtar N; Almajhdi FN; Zaman N; Suleman M; Ali SS; Waheed Y; Khan A
Front Cell Dev Biol; 2022; 10():940863. PubMed ID: 36733340
[No Abstract] [Full Text] [Related]
4. Insights into the Binding of Receptor-Binding Domain (RBD) of SARS-CoV-2 Wild Type and B.1.620 Variant with hACE2 Using Molecular Docking and Simulation Approaches.
Muhseen ZT; Kadhim S; Yahiya YI; Alatawi EA; Aba Alkhayl FF; Almatroudi A
Biology (Basel); 2021 Dec; 10(12):. PubMed ID: 34943225
[TBL] [Abstract][Full Text] [Related]
5. Receptor binding domain of SARS-CoV-2 from Wuhan strain to Omicron B.1.1.529 attributes increased affinity to variable structures of human ACE2.
Patil S; Alzahrani KJ; Banjer HJ; Halawani IF; Alzahrani H; Altayar MA; Albogami S; Angeles RF; Hassan AAA; Bhandi S; Raj AT
J Infect Public Health; 2022 Jul; 15(7):781-787. PubMed ID: 35738053
[TBL] [Abstract][Full Text] [Related]
6. Structural and functional insights into the major mutations of SARS-CoV-2 Spike RBD and its interaction with human ACE2 receptor.
Gurung AB; Ali MA; Lee J; Farah MA; Al-Anazi KM; Al-Hemaid F; Sami H
J King Saud Univ Sci; 2022 Feb; 34(2):101773. PubMed ID: 34955621
[TBL] [Abstract][Full Text] [Related]
7. Bioinformatics analysis of the differences in the binding profile of the wild-type and mutants of the SARS-CoV-2 spike protein variants with the ACE2 receptor.
Suleman M; Yousafi Q; Ali J; Ali SS; Hussain Z; Ali S; Waseem M; Iqbal A; Ahmad S; Khan A; Wang Y; Wei DQ
Comput Biol Med; 2021 Nov; 138():104936. PubMed ID: 34655895
[TBL] [Abstract][Full Text] [Related]
8. The SARS-CoV-2 B.1.618 variant slightly alters the spike RBD-ACE2 binding affinity and is an antibody escaping variant: a computational structural perspective.
Khan A; Gui J; Ahmad W; Haq I; Shahid M; Khan AA; Shah A; Khan A; Ali L; Anwar Z; Safdar M; Abubaker J; Uddin NN; Cao L; Wei DQ; Mohammad A
RSC Adv; 2021 Sep; 11(48):30132-30147. PubMed ID: 35480256
[TBL] [Abstract][Full Text] [Related]
9. Structural basis for the mechanism of interaction of SARS-CoV-2 B.1.640.2 variant RBD with the host receptors hACE2 and GRP78.
Shafiq A; Khalid U; Abdur Rehman U; Abdullah Almuqri E; Muddassir M; Ahmad S; Khan MI; Khan A; Wei DQ
J Biomol Struct Dyn; 2024; 42(4):2034-2042. PubMed ID: 37286365
[TBL] [Abstract][Full Text] [Related]
10. Molecular dynamic simulation suggests stronger interaction of Omicron-spike with ACE2 than wild but weaker than Delta SARS-CoV-2 can be blocked by engineered S1-RBD fraction.
Santra D; Maiti S
Struct Chem; 2022; 33(5):1755-1769. PubMed ID: 35966763
[TBL] [Abstract][Full Text] [Related]
11. In silico investigations of heparin binding to SARS-CoV-2 variants with a focus at the RBD/ACE2 interface.
Ali N; Khan R; AlAsmari AF; Kumar V
Process Biochem; 2022 Apr; 115():70-79. PubMed ID: 35194375
[TBL] [Abstract][Full Text] [Related]
12. Is BF.7 more infectious than other Omicron subtypes: Insights from structural and simulation studies of BF.7 spike RBD variant.
Singh JK; Anand S; Srivastava SK
Int J Biol Macromol; 2023 May; 238():124154. PubMed ID: 36965551
[TBL] [Abstract][Full Text] [Related]
13. AlphaFold2-Enabled Atomistic Modeling of Epistatic Binding Mechanisms for the SARS-CoV-2 Spike Omicron XBB.1.5, EG.5 and FLip Variants: Convergent Evolution Hotspots Cooperate to Control Stability and Conformational Adaptability in Balancing ACE2 Binding and Antibody Resistance.
Raisinghani N; Alshahrani M; Gupta G; Xiao S; Tao P; Verkhivker G
bioRxiv; 2023 Dec; ():. PubMed ID: 38168257
[TBL] [Abstract][Full Text] [Related]
14. Molecular screening of glycyrrhizin-based inhibitors against ACE2 host receptor of SARS-CoV-2.
Ahmad S; Waheed Y; Abro A; Abbasi SW; Ismail S
J Mol Model; 2021 Jun; 27(7):206. PubMed ID: 34169390
[TBL] [Abstract][Full Text] [Related]
15. Structural communication fingerprinting and dynamic investigation of RBD-hACE2 complex from BA.1 × AY.4 recombinant variant (Deltacron) of SARS-CoV-2 to decipher the structural basis for enhanced transmission.
Wang J; Fatima Muhammad S; Aman S; Khan A; Munir S; Khan M; Mohammad A; Waheed Y; Munir M; Guo L; Chen L; Wei DQ
J Biomol Struct Dyn; 2023; 41(16):7665-7676. PubMed ID: 36129018
[TBL] [Abstract][Full Text] [Related]
16. Probing structural basis for enhanced binding of SARS-CoV-2 P.1 variant spike protein with the human ACE2 receptor.
Lata S; Akif M
J Cell Biochem; 2022 Jul; 123(7):1207-1221. PubMed ID: 35620980
[TBL] [Abstract][Full Text] [Related]
17. The Omicron (B.1.1.529) variant of SARS-CoV-2 binds to the hACE2 receptor more strongly and escapes the antibody response: Insights from structural and simulation data.
Khan A; Waris H; Rafique M; Suleman M; Mohammad A; Ali SS; Khan T; Waheed Y; Liao C; Wei DQ
Int J Biol Macromol; 2022 Mar; 200():438-448. PubMed ID: 35063482
[TBL] [Abstract][Full Text] [Related]
18. Tetracycline as an inhibitor to the SARS-CoV-2.
Zhao TY; Patankar NA
J Cell Biochem; 2021 Jul; 122(7):752-759. PubMed ID: 33619758
[TBL] [Abstract][Full Text] [Related]
19. Investigating the role of glycans in Omicron sub-lineages XBB.1.5 and XBB.1.16 binding to host receptor using molecular dynamics and binding free energy calculations.
Singh JK; Singh J; Srivastava SK
J Comput Aided Mol Des; 2023 Nov; 37(11):551-563. PubMed ID: 37542610
[TBL] [Abstract][Full Text] [Related]
20. A recombinant spike-XBB.1.5 protein vaccine induces broad-spectrum immune responses against XBB.1.5-included Omicron variants of SARS-CoV-2.
He C; Alu A; Lei H; Yang J; Hong W; Song X; Li J; Yang L; Wang W; Shen G; Lu G; Wei X
MedComm (2020); 2023 Jun; 4(3):e263. PubMed ID: 37125241
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
